NorthWest Biotherapeutics Inc (NWBO)

[abeta]

Adam Feuerstein -

I hate to break the bad news to Seeking Alpha contributor Josh Ginsburg,

but Northwest's DCVax is not different from ImmunoCellular's ICT-107.

DCVax will fail just like ICT-107 failed because dendritic cancer vaccines are too weak to overcome cancer's innate ability to overpower or evade the body's immune system.

insert-text-here

ICT never got out of Phase 2 and we are wrapping up Phase 3

In fact -
Right now - DCVax at -

28.2% = 92 ALIVE = at least 36 months

And NO patients used grapefruit juice .....

TOE PICK?

insert-text-here